News
NICE ‘no’ for Orchard Therapeutics’ gene therapy Libmeldy
The National Institute for Health and Care Excellence (NICE) has announced that it does not recommend Orchard Therapeutics’ gene therapy Libmeldy for the treatment of metachromatic leukodystrophy (MLD) in children.